GENESIS LADINEZ VELEZ: Open Payments
NPI 1255044517 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 14 payments from 3 companies in 2025. Trend: 2023 $249 · 2024 $175 · 2025 $910
Food & beverage: $826Education: $84
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $719 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $66 |
Products named: UZEDY, AUSTEDO XR, TEZSPIRE, CAPLYTA.
Industry payments across CT — which companies pay providers there.
